Nasdaq
LABT
Lakewood-Amedex Biotherapeutics Inc.
- Health Care
- 1 day
- −3.5%
- 1 month
- −6.7%
- 1 year
- —
$2.23 · Mkt cap $5.28M
At the 6 Aug 2026 close
Nasdaq
Lakewood-Amedex Biotherapeutics Inc.
$2.23 · Mkt cap $5.28M
At the 6 Aug 2026 close
Lakewood-Amedex Biotherapeutics Inc. trades under the ticker LABT on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $5.28M. The last closing price was $2.23, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because LABT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.